Report cover image

Global Pregnancy Medication Market by Size, by Type, by Application, by Region, History and Forecast 2020-2031

Publisher APO Research, Inc.
Published Aug 16, 2025
Length 198 Pages
SKU # APRC20355499

Description

Summary

According to APO Research, The global Pregnancy Medication market is projected to grow from US$ million in 2025 to US$ million by 2031, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Pregnancy Medication is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Pregnancy Medication is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The China market for Pregnancy Medication is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Europe market for Pregnancy Medication is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global manufacturers of Pregnancy Medication include Janssen, Takeda, Sanofi, Pfizer, GSK, AbbVie, Viatris Inc(Mylan Inc.), Sun Pharma and Roche Holding AG, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Pregnancy Medication, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2020-2024, estimates for 2025, and projections of CAGR through 2031.

This report researches the key producers of Pregnancy Medication, also provides the sales of main regions and countries. Of the upcoming market potential for Pregnancy Medication, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Pregnancy Medication sales, revenue, market share and industry ranking of main manufacturers, data from 2020 to 2025. Identification of the major stakeholders in the global Pregnancy Medication market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2020 to 2031. Evaluation and forecast the market size for Pregnancy Medication sales, projected growth trends, production technology, application and end-user industry.

Pregnancy Medication Segment by Company

Janssen
Takeda
Sanofi
Pfizer
GSK
AbbVie
Viatris Inc(Mylan Inc.)
Sun Pharma
Roche Holding AG
Regeneron
Piramal Enterprises Limited
Lupin Limited
Glenmark Pharmaceuticals Ltd
Dr. Reddy's Laboratories
Cipla Inc
Amgen Inc
Alkem Laboratories Limited
Alembic Pharmaceuticals Ltd
Pregnancy Medication Segment by Type

Antiallergic
Antimicrobials
Antianemia
Antacids
Laxatives
Vaccines
Nutritional Supplements
Analgesics
Others
Pregnancy Medication Segment by Application

Hospital Pharmacy
Online Pharmacy
Retail Pharmacy
Pregnancy Medication Segment by Region

North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pregnancy Medication market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Pregnancy Medication and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pregnancy Medication.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Pregnancy Medication market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2020-2031).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Pregnancy Medication manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Pregnancy Medication in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Pregnancy Medication in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report

Table of Contents

198 Pages
1 Market Overview
1.1 Product Definition
1.2 Global Pregnancy Medication Market Size, 2020 VS 2024 VS 2031
1.3 Global Pregnancy Medication Market Size Estimates and Forecasts (2020-2031)
1.4 Global Pregnancy Medication Sales Estimates and Forecasts (2020-2031)
1.5 Global Pregnancy Medication Market Average Price (2020-2031)
1.6 Assumptions and Limitations
1.7 Study Goals and Objectives
2 Global Pregnancy Medication Market Dynamics
2.1 Pregnancy Medication Industry Trends
2.2 Pregnancy Medication Industry Drivers
2.3 Pregnancy Medication Industry Opportunities and Challenges
2.4 Pregnancy Medication Industry Restraints
3 Pregnancy Medication Market by Manufacturers
3.1 Global Pregnancy Medication Revenue by Manufacturers (2020-2025)
3.2 Global Pregnancy Medication Sales by Manufacturers (2020-2025)
3.3 Global Pregnancy Medication Average Sales Price by Manufacturers (2020-2025)
3.4 Global Pregnancy Medication Industry Manufacturers Ranking, 2023 VS 2024 VS 2025
3.5 Global Pregnancy Medication Key Manufacturers Manufacturing Sites & Headquarters
3.6 Global Pregnancy Medication Manufacturers, Product Type & Application
3.7 Global Pregnancy Medication Manufacturers Establishment Date
3.8 Market Competitive Analysis
3.8.1 Global Pregnancy Medication Market CR5 and HHI
3.8.2 Global Top 5 and 10 Pregnancy Medication Players Market Share by Revenue in 2024
3.8.3 2024 Pregnancy Medication Tier 1, Tier 2, and Tier 3
4 Pregnancy Medication Market by Type
4.1 Pregnancy Medication Type Introduction
4.1.1 Antiallergic
4.1.2 Antimicrobials
4.1.3 Antianemia
4.1.4 Antacids
4.1.5 Laxatives
4.1.6 Vaccines
4.1.7 Nutritional Supplements
4.1.8 Analgesics
4.1.9 Others
4.2 Global Pregnancy Medication Sales by Type
4.2.1 Global Pregnancy Medication Sales by Type (2020 VS 2024 VS 2031)
4.2.2 Global Pregnancy Medication Sales by Type (2020-2031)
4.2.3 Global Pregnancy Medication Sales Market Share by Type (2020-2031)
4.3 Global Pregnancy Medication Revenue by Type
4.3.1 Global Pregnancy Medication Revenue by Type (2020 VS 2024 VS 2031)
4.3.2 Global Pregnancy Medication Revenue by Type (2020-2031)
4.3.3 Global Pregnancy Medication Revenue Market Share by Type (2020-2031)
5 Pregnancy Medication Market by Application
5.1 Pregnancy Medication Application Introduction
5.1.1 Hospital Pharmacy
5.1.2 Online Pharmacy
5.1.3 Retail Pharmacy
5.2 Global Pregnancy Medication Sales by Application
5.2.1 Global Pregnancy Medication Sales by Application (2020 VS 2024 VS 2031)
5.2.2 Global Pregnancy Medication Sales by Application (2020-2031)
5.2.3 Global Pregnancy Medication Sales Market Share by Application (2020-2031)
5.3 Global Pregnancy Medication Revenue by Application
5.3.1 Global Pregnancy Medication Revenue by Application (2020 VS 2024 VS 2031)
5.3.2 Global Pregnancy Medication Revenue by Application (2020-2031)
5.3.3 Global Pregnancy Medication Revenue Market Share by Application (2020-2031)
6 Global Pregnancy Medication Sales by Region
6.1 Global Pregnancy Medication Sales by Region: 2020 VS 2024 VS 2031
6.2 Global Pregnancy Medication Sales by Region (2020-2031)
6.2.1 Global Pregnancy Medication Sales by Region (2020-2025)
6.2.2 Global Pregnancy Medication Sales Forecasted by Region (2025-2030)
6.3 North America
6.3.1 North America Pregnancy Medication Sales Growth Rate by Country: 2020 VS 2024 VS 2031
6.3.2 North America Pregnancy Medication Sales by Country (2020-2031)
6.3.3 U.S.
6.3.4 Canada
6.3.5 Mexico
6.4 Europe
6.4.1 Europe Pregnancy Medication Sales Growth Rate by Country: 2020 VS 2024 VS 2031
6.4.2 Europe Pregnancy Medication Sales by Country (2020-2031)
6.4.3 Germany
6.4.4 France
6.4.5 U.K.
6.4.6 Italy
6.4.7 Netherlands
6.5 Asia Pacific
6.5.1 Asia Pacific Pregnancy Medication Sales Growth Rate by Country: 2020 VS 2024 VS 2031
6.5.2 Asia Pacific Pregnancy Medication Sales by Country (2020-2031)
6.5.3 China
6.5.4 Japan
6.5.5 South Korea
6.5.6 Southeast Asia
6.5.7 India
6.5.8 Australia
6.6 South America, Middle East and Africa
6.6.1 South America, Middle East and Africa Pregnancy Medication Sales Growth Rate by Country: 2020 VS 2024 VS 2031
6.6.2 South America, Middle East and Africa Pregnancy Medication Sales by Country (2020-2031)
6.6.3 Brazil
6.6.4 South Africa
6.6.5 Saudi Arabia
6.6.6 Turkey
6.6.6 Argentina
6.6.6 UAE
6.6.6 Egypt
6.6.6 Chile
7 Global Pregnancy Medication Revenue by Region
7.1 Global Pregnancy Medication Revenue by Region
7.1.1 Global Pregnancy Medication Revenue by Region: 2020 VS 2024 VS 2031
7.1.2 Global Pregnancy Medication Revenue by Region (2020-2025)
7.1.3 Global Pregnancy Medication Revenue by Region (2026-2031)
7.1.4 Global Pregnancy Medication Revenue Market Share by Region (2020-2031)
7.2 North America
7.2.1 North America Pregnancy Medication Revenue (2020-2031)
7.2.2 North America Pregnancy Medication Revenue Share by Country: 2020 VS 2024 VS 2031
7.3 Europe
7.3.1 Europe Pregnancy Medication Revenue (2020-2031)
7.3.2 Europe Pregnancy Medication Revenue Share by Country: 2020 VS 2024 VS 2031
7.4 Asia-Pacific
7.4.1 Asia-Pacific Pregnancy Medication Revenue (2020-2031)
7.4.2 Asia-Pacific Pregnancy Medication Revenue Share by Country: 2020 VS 2024 VS 2031
7.5 South America, Middle East and Africa
7.5.1 South America, Middle East and Africa Pregnancy Medication Revenue (2020-2031)
7.5.2 South America, Middle East and Africa Pregnancy Medication Revenue Share by Country: 2020 VS 2024 VS 2031
8 Company Profiles
8.1 Janssen
8.1.1 Janssen Comapny Information
8.1.2 Janssen Business Overview
8.1.3 Janssen Pregnancy Medication Sales, Price, Revenue and Gross Margin (2020-2025)
8.1.4 Janssen Pregnancy Medication Product Portfolio
8.1.5 Janssen Recent Developments
8.2 Takeda
8.2.1 Takeda Comapny Information
8.2.2 Takeda Business Overview
8.2.3 Takeda Pregnancy Medication Sales, Price, Revenue and Gross Margin (2020-2025)
8.2.4 Takeda Pregnancy Medication Product Portfolio
8.2.5 Takeda Recent Developments
8.3 Sanofi
8.3.1 Sanofi Comapny Information
8.3.2 Sanofi Business Overview
8.3.3 Sanofi Pregnancy Medication Sales, Price, Revenue and Gross Margin (2020-2025)
8.3.4 Sanofi Pregnancy Medication Product Portfolio
8.3.5 Sanofi Recent Developments
8.4 Pfizer
8.4.1 Pfizer Comapny Information
8.4.2 Pfizer Business Overview
8.4.3 Pfizer Pregnancy Medication Sales, Price, Revenue and Gross Margin (2020-2025)
8.4.4 Pfizer Pregnancy Medication Product Portfolio
8.4.5 Pfizer Recent Developments
8.5 GSK
8.5.1 GSK Comapny Information
8.5.2 GSK Business Overview
8.5.3 GSK Pregnancy Medication Sales, Price, Revenue and Gross Margin (2020-2025)
8.5.4 GSK Pregnancy Medication Product Portfolio
8.5.5 GSK Recent Developments
8.6 AbbVie
8.6.1 AbbVie Comapny Information
8.6.2 AbbVie Business Overview
8.6.3 AbbVie Pregnancy Medication Sales, Price, Revenue and Gross Margin (2020-2025)
8.6.4 AbbVie Pregnancy Medication Product Portfolio
8.6.5 AbbVie Recent Developments
8.7 Viatris Inc(Mylan Inc.)
8.7.1 Viatris Inc(Mylan Inc.) Comapny Information
8.7.2 Viatris Inc(Mylan Inc.) Business Overview
8.7.3 Viatris Inc(Mylan Inc.) Pregnancy Medication Sales, Price, Revenue and Gross Margin (2020-2025)
8.7.4 Viatris Inc(Mylan Inc.) Pregnancy Medication Product Portfolio
8.7.5 Viatris Inc(Mylan Inc.) Recent Developments
8.8 Sun Pharma
8.8.1 Sun Pharma Comapny Information
8.8.2 Sun Pharma Business Overview
8.8.3 Sun Pharma Pregnancy Medication Sales, Price, Revenue and Gross Margin (2020-2025)
8.8.4 Sun Pharma Pregnancy Medication Product Portfolio
8.8.5 Sun Pharma Recent Developments
8.9 Roche Holding AG
8.9.1 Roche Holding AG Comapny Information
8.9.2 Roche Holding AG Business Overview
8.9.3 Roche Holding AG Pregnancy Medication Sales, Price, Revenue and Gross Margin (2020-2025)
8.9.4 Roche Holding AG Pregnancy Medication Product Portfolio
8.9.5 Roche Holding AG Recent Developments
8.10 Regeneron
8.10.1 Regeneron Comapny Information
8.10.2 Regeneron Business Overview
8.10.3 Regeneron Pregnancy Medication Sales, Price, Revenue and Gross Margin (2020-2025)
8.10.4 Regeneron Pregnancy Medication Product Portfolio
8.10.5 Regeneron Recent Developments
8.11 Piramal Enterprises Limited
8.11.1 Piramal Enterprises Limited Comapny Information
8.11.2 Piramal Enterprises Limited Business Overview
8.11.3 Piramal Enterprises Limited Pregnancy Medication Sales, Price, Revenue and Gross Margin (2020-2025)
8.11.4 Piramal Enterprises Limited Pregnancy Medication Product Portfolio
8.11.5 Piramal Enterprises Limited Recent Developments
8.12 Lupin Limited
8.12.1 Lupin Limited Comapny Information
8.12.2 Lupin Limited Business Overview
8.12.3 Lupin Limited Pregnancy Medication Sales, Price, Revenue and Gross Margin (2020-2025)
8.12.4 Lupin Limited Pregnancy Medication Product Portfolio
8.12.5 Lupin Limited Recent Developments
8.13 Glenmark Pharmaceuticals Ltd
8.13.1 Glenmark Pharmaceuticals Ltd Comapny Information
8.13.2 Glenmark Pharmaceuticals Ltd Business Overview
8.13.3 Glenmark Pharmaceuticals Ltd Pregnancy Medication Sales, Price, Revenue and Gross Margin (2020-2025)
8.13.4 Glenmark Pharmaceuticals Ltd Pregnancy Medication Product Portfolio
8.13.5 Glenmark Pharmaceuticals Ltd Recent Developments
8.14 Dr. Reddy's Laboratories
8.14.1 Dr. Reddy's Laboratories Comapny Information
8.14.2 Dr. Reddy's Laboratories Business Overview
8.14.3 Dr. Reddy's Laboratories Pregnancy Medication Sales, Price, Revenue and Gross Margin (2020-2025)
8.14.4 Dr. Reddy's Laboratories Pregnancy Medication Product Portfolio
8.14.5 Dr. Reddy's Laboratories Recent Developments
8.15 Cipla Inc
8.15.1 Cipla Inc Comapny Information
8.15.2 Cipla Inc Business Overview
8.15.3 Cipla Inc Pregnancy Medication Sales, Price, Revenue and Gross Margin (2020-2025)
8.15.4 Cipla Inc Pregnancy Medication Product Portfolio
8.15.5 Cipla Inc Recent Developments
8.16 Amgen Inc
8.16.1 Amgen Inc Comapny Information
8.16.2 Amgen Inc Business Overview
8.16.3 Amgen Inc Pregnancy Medication Sales, Price, Revenue and Gross Margin (2020-2025)
8.16.4 Amgen Inc Pregnancy Medication Product Portfolio
8.16.5 Amgen Inc Recent Developments
8.17 Alkem Laboratories Limited
8.17.1 Alkem Laboratories Limited Comapny Information
8.17.2 Alkem Laboratories Limited Business Overview
8.17.3 Alkem Laboratories Limited Pregnancy Medication Sales, Price, Revenue and Gross Margin (2020-2025)
8.17.4 Alkem Laboratories Limited Pregnancy Medication Product Portfolio
8.17.5 Alkem Laboratories Limited Recent Developments
8.18 Alembic Pharmaceuticals Ltd
8.18.1 Alembic Pharmaceuticals Ltd Comapny Information
8.18.2 Alembic Pharmaceuticals Ltd Business Overview
8.18.3 Alembic Pharmaceuticals Ltd Pregnancy Medication Sales, Price, Revenue and Gross Margin (2020-2025)
8.18.4 Alembic Pharmaceuticals Ltd Pregnancy Medication Product Portfolio
8.18.5 Alembic Pharmaceuticals Ltd Recent Developments
9 Value Chain and Sales Channels Analysis
9.1 Pregnancy Medication Value Chain Analysis
9.1.1 Pregnancy Medication Key Raw Materials
9.1.2 Raw Materials Key Suppliers
9.1.3 Manufacturing Cost Structure
9.1.4 Pregnancy Medication Production Mode & Process
9.2 Pregnancy Medication Sales Channels Analysis
9.2.1 Direct Comparison with Distribution Share
9.2.2 Pregnancy Medication Distributors
9.2.3 Pregnancy Medication Customers
10 Concluding Insights
11 Appendix
11.1 Reasons for Doing This Study
11.2 Research Methodology
11.3 Research Process
11.4 Authors List of This Report
11.5 Data Source
11.5.1 Secondary Sources
11.5.2 Primary Sources
11.6 Disclaimer
How Do Licenses Work?
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.